IL156100A0 - Crystalline glucosamine sulphate metal salts - Google Patents

Crystalline glucosamine sulphate metal salts

Info

Publication number
IL156100A0
IL156100A0 IL15610001A IL15610001A IL156100A0 IL 156100 A0 IL156100 A0 IL 156100A0 IL 15610001 A IL15610001 A IL 15610001A IL 15610001 A IL15610001 A IL 15610001A IL 156100 A0 IL156100 A0 IL 156100A0
Authority
IL
Israel
Prior art keywords
metal salts
glucosamine sulphate
crystalline glucosamine
novel crystalline
present
Prior art date
Application number
IL15610001A
Other languages
English (en)
Original Assignee
Nicholas Piramal India Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nicholas Piramal India Ltd filed Critical Nicholas Piramal India Ltd
Publication of IL156100A0 publication Critical patent/IL156100A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H5/00Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
    • C07H5/04Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to nitrogen
    • C07H5/06Aminosugars
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H5/00Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
    • C07H5/04Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to nitrogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
IL15610001A 2000-12-01 2001-12-03 Crystalline glucosamine sulphate metal salts IL156100A0 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IN1088MU2000 2000-12-01
IN1087MU2000 2000-12-01
IN394MU2001 2001-04-26
PCT/IN2001/000211 WO2002043653A2 (fr) 2000-12-01 2001-12-03 Sels metalliques de sulfate de glucosamine cristallin et processus de preparation de ces sels

Publications (1)

Publication Number Publication Date
IL156100A0 true IL156100A0 (en) 2003-12-23

Family

ID=27272463

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15610001A IL156100A0 (en) 2000-12-01 2001-12-03 Crystalline glucosamine sulphate metal salts
IL156100A IL156100A (en) 2000-12-01 2003-05-25 Crystalline glucosamine sulphate metal salts, methods for their preparation and pharmaceutical compositions containing them

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL156100A IL156100A (en) 2000-12-01 2003-05-25 Crystalline glucosamine sulphate metal salts, methods for their preparation and pharmaceutical compositions containing them

Country Status (29)

Country Link
US (1) US6812223B2 (fr)
EP (1) EP1347986B1 (fr)
JP (1) JP4307072B2 (fr)
KR (1) KR100842400B1 (fr)
CN (1) CN100351261C (fr)
AT (1) ATE293122T1 (fr)
AU (2) AU2002217416B2 (fr)
BG (1) BG107845A (fr)
BR (1) BR0115801A (fr)
CA (1) CA2436925C (fr)
CZ (1) CZ20031503A3 (fr)
DE (1) DE60110118T2 (fr)
DK (1) DK1347986T3 (fr)
DZ (1) DZ3450A1 (fr)
EA (1) EA006632B1 (fr)
ES (1) ES2240570T3 (fr)
HR (1) HRP20030400A2 (fr)
HU (1) HU229546B1 (fr)
IL (2) IL156100A0 (fr)
MA (1) MA25925A1 (fr)
MX (1) MXPA03004693A (fr)
NO (1) NO324847B1 (fr)
NZ (1) NZ526079A (fr)
PL (1) PL207740B1 (fr)
PT (1) PT1347986E (fr)
RO (1) RO121738B1 (fr)
SI (1) SI21188A (fr)
SK (1) SK285926B6 (fr)
WO (1) WO2002043653A2 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20012818A1 (it) 2001-12-28 2003-06-28 Acraf Un metodo per preparare un composto della glucosammina e composto cosi ottenuto
JP2006508643A (ja) 2002-07-01 2006-03-16 アーキオン ライフ サイエンシーズ エルエルシー ディー/ビー/エー バイオ−テクニカル リソーセズ ディビジョン グルコサミンおよびn−アセチルグルコサミン製造のためのプロセスおよび材料
US7388001B1 (en) 2004-09-17 2008-06-17 Jfc Technolries, Llc Halide-free glucosamine sulfate compositions and methods of preparation
US7388000B1 (en) 2004-09-17 2008-06-17 Jfct Technologies, Llc Halide-free glucosamine phosphate compositions and methods of preparation
US7683042B1 (en) 2004-09-17 2010-03-23 Jfc Technologies, Llc Stabilized halide-free glucosamine base and method of preparation
US7511134B1 (en) 2004-09-22 2009-03-31 Jfc Technologies Method for preparing N-acetylglucosamine
DE102005033844A1 (de) * 2005-07-20 2007-02-01 Beiersdorf Ag Insektenabwehrmittel mit Langzeitwirkung
US7854956B2 (en) * 2007-03-07 2010-12-21 Exportadora De Sal, S.A. De C.V. Low sodium salt compositions and methods of preparation and uses thereof
CN101735283B (zh) * 2008-11-14 2012-07-18 徐州海吉亚生物制品有限公司 一种氨基葡萄糖盐酸盐与氨基葡萄糖硫酸钾/钠盐的共结晶技术
CA2779168A1 (fr) * 2009-11-05 2011-05-12 Pharma Base India Pvt. Ltd. Procede d'elaboration d'un melange salin de sulfate de glucosamine et d'un chlorure de metal alcalin
CN106866751B (zh) * 2017-02-17 2019-11-05 江苏双林海洋生物药业有限公司 一种硫酸氨基葡萄糖复盐的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1148050B (it) * 1981-04-30 1986-11-26 Rotta Research Lab Composto stabile della glucosamina solfato procedimento per la sua preparazione e composizioni farmaceutiche contenenti tale composto
DE3532081A1 (de) * 1985-09-09 1987-03-12 Orion Yhtymae Oy Mischsalze von glucosaminsulfat und verfahren zu ihrer herstellung
CH690719A5 (it) * 1996-08-19 2000-12-29 Rotta Res B V Amsterdam Swiss Procedimento per la preparazione di sali misti della glucosamina.
US5843923A (en) * 1998-05-22 1998-12-01 Jame Fine Chemicals, Inc. Glucosamine sulfate potassium chloride and process of preparation thereof

Also Published As

Publication number Publication date
US6812223B2 (en) 2004-11-02
EP1347986B1 (fr) 2005-04-13
CA2436925A1 (fr) 2002-06-06
SK285926B6 (sk) 2007-11-02
CN1479744A (zh) 2004-03-03
WO2002043653A3 (fr) 2003-01-03
CA2436925C (fr) 2008-10-14
CZ20031503A3 (cs) 2003-10-15
HRP20030400A2 (en) 2005-10-31
BR0115801A (pt) 2005-12-13
NZ526079A (en) 2005-07-29
MA25925A1 (fr) 2003-10-01
EP1347986A2 (fr) 2003-10-01
PL366386A1 (en) 2005-01-24
CN100351261C (zh) 2007-11-28
DE60110118T2 (de) 2006-03-02
HUP0302154A3 (en) 2006-01-30
ES2240570T3 (es) 2005-10-16
ATE293122T1 (de) 2005-04-15
SK6482003A3 (en) 2003-09-11
WO2002043653B1 (fr) 2003-05-22
EP1347986A4 (fr) 2004-01-21
KR20030055336A (ko) 2003-07-02
JP4307072B2 (ja) 2009-08-05
WO2002043653A2 (fr) 2002-06-06
PT1347986E (pt) 2005-08-31
US20040030121A1 (en) 2004-02-12
MXPA03004693A (es) 2005-04-19
DE60110118D1 (de) 2005-05-19
RO121738B1 (ro) 2008-03-28
EA006632B1 (ru) 2006-02-24
NO20032491L (no) 2003-07-30
NO20032491D0 (no) 2003-06-02
DK1347986T3 (da) 2005-08-15
SI21188A (sl) 2003-10-31
NO324847B1 (no) 2007-12-17
EA200300614A1 (ru) 2004-10-28
HU229546B1 (hu) 2014-01-28
DZ3450A1 (fr) 2002-06-06
IL156100A (en) 2009-09-01
JP2004529860A (ja) 2004-09-30
HUP0302154A2 (hu) 2003-10-28
AU2002217416B2 (en) 2007-02-08
BG107845A (bg) 2004-08-31
KR100842400B1 (ko) 2008-07-01
AU1741602A (en) 2002-06-11
PL207740B1 (pl) 2011-01-31

Similar Documents

Publication Publication Date Title
IL156100A0 (en) Crystalline glucosamine sulphate metal salts
MX2009003305A (es) Inhibidores de co-transportador de glucosa de sodio 2 y metodo para su uso.
BR0209957A (pt) Composto, processo para a preparação de um composto, composição farmacêutica que compreende um composto, utilização desse composto e processo para o tratamento e profilaxia de artrite, diabetes, distúrbios alimentares e obesidade
CA2288445A1 (fr) Derives de l'acide pyrrolid-2-one-5-hydroxamique
RU2005115855A (ru) Композиция трамадола продлонгированного высвобождением с 24-часовым действием
MY157828A (en) Combination therapy with sglt-2 inhibitors and their pharmaceutical compositions
GR3037073T3 (en) Pyridylfuran and pyridylthiophene compounds and pharmaceutical use thereof
UA87154C2 (uk) Полісульфатовані глікозиди та їх солі
BRPI0520050A2 (pt) composto, processo para a preparação de um composto e processo de glicosilação estereoseletiva para a preparação de mais de 99% de anÈmero b enriquecido de hidrocloreto de gencitabina
EP1885380A4 (fr) Compositions pharmaceutiques comprenant un acide arsenieux, ses sels de sodium et ses derives destines au traitement de cancer uro-genital et de ses metastases
NZ581390A (en) Prebiotics comprising an oligosaccharide, sialyloligosaccharide and free sialic acid
WO2004017998A3 (fr) Composition topique
CA2341031A1 (fr) Forme de sel de pantoprazole
CA2527365A1 (fr) Compositions de prevention et de traitement de symptome de type rhume et grippe comprenant du zinc chelate
AU2003269146A1 (en) Process for the preparation of sodium ferric gluconate complex in sucrose
LT2003051A (en) Crystalline glucosamine sulphate metal salts and process for preparing the same
WO2006017590A3 (fr) Utilisation de pyruvate de méthyle pour réduire la prise de poids chez les mammifères
WO2003094905A8 (fr) Composition a base de diclofenac pour traitement local de troubles de cavite oropharyngee
WO2006015232A3 (fr) Utilisation de pyruvate de methyle en vue d'augmenter la production d'energie musculaire
BRPI0413458A (pt) compostos, processo para a sua preparação, composição farmacêutica que compreende os mesmos, utilização de um composto, métodos para o tratamento e profilaxia de artrite, diabetes, distúrbios alimentares e obesidade
AU2003223070A1 (en) Obg3 fragments inhibiting the conversion of active obg3 into less active obg3 and other compositions for treatment of metabolic disorders
ECSP034670A (es) Sales de metal cristalinas de sulfato de glucosamina y procedimientos para su preparacion
EP2320870A1 (fr) Composition intranasale topique utilisable dans le cas d'une obstruction nasale
NZ607724A (en) Topical medicament for treating or preventing pain
TW200602057A (en) Medicaments containing n-sulfamoyl-n' -arylpiperazines for the prophylaxis or treatment of obesity and related conditions